Analyst consensus rating
InspireMD Analyst Rating: none
Direct answer
InspireMD's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $3.33.
Forecast evidence checked October 19, 2026.
Get free InspireMD email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.46
- Average price target
- $3.33
- High price target
- $4.00
- Low price target
- $3.00
- Low target gap
- +559.1%
- Target upside
- +632.3%
- High target gap
- +778.7%
- Target range width
- 219.7%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- October 19, 2026
- Valid through
- October 26, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for InspireMD?
InspireMD has a verified none consensus. The same dataset has an average price target of $3.33.
How far are InspireMD's low and high targets from the recorded price?
The low target implies +559.1%, while the high target implies +778.7%.
How many analysts are included in InspireMD's consensus?
The verified consensus includes 3 analysts.
How is InspireMD's target upside or downside calculated?
The average target of $3.33 is divided by the recorded price of $0.46, then one is subtracted to produce +632.3%. This does not guarantee a future return.
When was InspireMD's analyst forecast verified?
The data was verified on 2026-10-19. The dataset is valid through 2026-10-26.